Analysts expect Mesoblast Ltd to report revenue of 177.65 M for 2027, against a range of 169.97 M to 185.33 M. The most recent reported year, 2026, came in at 120.25 M, a 0.6% miss against the 120.93 M consensus.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 10.21 M | 7.50 M | 5.90 M | 17.20 M | 120.25 M | - | - | ||
| High Estimate | 14.59 M | 8.87 M | 7.71 M | 18.96 M | 125.74 M | 185.33 M | 341.64 M | ||
| Low Estimate | 12.02 M | 7.38 M | 6.41 M | 17.72 M | 116.12 M | 169.97 M | 294.26 M | ||
| Consensus Estimate | 13.30 M | 8.12 M | 7.06 M | 18.34 M | 120.93 M | 177.65 M | 317.95 M |
Analysts expect Mesoblast Ltd to report earnings per share of -0.22 for 2027, against a range of -0.23 to -0.21. The most recent reported year, 2026, came in at -0.44, a 6.4% beat against the -0.47 consensus.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.33 | -1.05 | -0.89 | -0.85 | -0.44 | - | - | ||
| High Estimate | -0.96 | -1.06 | -0.51 | -0.53 | -0.45 | -0.21 | 0.17 | ||
| Low Estimate | -1.08 | -1.24 | -0.57 | -0.59 | -0.49 | -0.23 | 0.15 | ||
| Consensus Estimate | -1.02 | -1.15 | -0.54 | -0.56 | -0.47 | -0.22 | 0.16 |
Pull Wall Street consensus for Mesoblast Ltd (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MESO&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MESO", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MESO&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();